Copyright Reports & Markets. All rights reserved.

Global G-CSF and G-CSF Biosimilars Sales Market Report 2021

Request for Sample of this report
Buy now

1 G-CSF and G-CSF Biosimilars Market Overview

  • 1.1 G-CSF and G-CSF Biosimilars Product Scope
  • 1.2 G-CSF and G-CSF Biosimilars Segment by Type
    • 1.2.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Blood Disorders
    • 1.2.3 Oncology Diseases
    • 1.2.4 Chronic And Autoimmune Diseases
    • 1.2.5 Growth Hormone Deficiencies
  • 1.3 G-CSF and G-CSF Biosimilars Segment by Application
    • 1.3.1 Global G-CSF and G-CSF Biosimilars Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Human Growth Hormone
    • 1.3.3 Erythropoietin
    • 1.3.4 Monoclonal Antibodies
    • 1.3.5 Insulin
    • 1.3.6 Interferon
  • 1.4 G-CSF and G-CSF Biosimilars Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global G-CSF and G-CSF Biosimilars Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global G-CSF and G-CSF Biosimilars Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global G-CSF and G-CSF Biosimilars Price Trends (2016-2027)

2 G-CSF and G-CSF Biosimilars Estimates and Forecasts by Region

  • 2.1 Global G-CSF and G-CSF Biosimilars Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2016-2021)
    • 2.2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2016-2021)
  • 2.3 Global G-CSF and G-CSF Biosimilars Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global G-CSF and G-CSF Biosimilars Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)
    • 2.4.2 Europe G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)
    • 2.4.3 China G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)
    • 2.4.4 Japan G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)
    • 2.4.6 India G-CSF and G-CSF Biosimilars Estimates and Projections (2016-2027)

3 Global G-CSF and G-CSF Biosimilars Competition Landscape by Players

  • 3.1 Global Top G-CSF and G-CSF Biosimilars Players by Sales (2016-2021)
  • 3.2 Global Top G-CSF and G-CSF Biosimilars Players by Revenue (2016-2021)
  • 3.3 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2020)
  • 3.4 Global G-CSF and G-CSF Biosimilars Average Price by Company (2016-2021)
  • 3.5 Manufacturers G-CSF and G-CSF Biosimilars Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global G-CSF and G-CSF Biosimilars Market Size by Type

  • 4.1 Global G-CSF and G-CSF Biosimilars Historic Market Review by Type (2016-2021)
    • 4.1.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2016-2021)
    • 4.1.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global G-CSF and G-CSF Biosimilars Price by Type (2016-2021)
  • 4.2 Global G-CSF and G-CSF Biosimilars Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Type (2022-2027)
    • 4.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global G-CSF and G-CSF Biosimilars Price Forecast by Type (2022-2027)

5 Global G-CSF and G-CSF Biosimilars Market Size by Application

  • 5.1 Global G-CSF and G-CSF Biosimilars Historic Market Review by Application (2016-2021)
    • 5.1.1 Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2016-2021)
    • 5.1.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global G-CSF and G-CSF Biosimilars Price by Application (2016-2021)
  • 5.2 Global G-CSF and G-CSF Biosimilars Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Application (2022-2027)
    • 5.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global G-CSF and G-CSF Biosimilars Price Forecast by Application (2022-2027)

6 North America G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 6.1 North America G-CSF and G-CSF Biosimilars Sales by Company
    • 6.1.1 North America G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 6.1.2 North America G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 6.2 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 6.2.1 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 6.3 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 6.3.1 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2022-2027)

7 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 7.1 Europe G-CSF and G-CSF Biosimilars Sales by Company
    • 7.1.1 Europe G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 7.1.2 Europe G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 7.2 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 7.2.1 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 7.3 Europe G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 8.1 China G-CSF and G-CSF Biosimilars Sales by Company
    • 8.1.1 China G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 8.1.2 China G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 8.2 China G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 8.2.1 China G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 8.2.2 China G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 8.3 China G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 8.3.1 China 158 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 158 Sales Breakdown by Application (2022-2027)

9 Japan G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 9.1 Japan G-CSF and G-CSF Biosimilars Sales by Company
    • 9.1.1 Japan G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 9.1.2 Japan G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 9.2 Japan G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 9.2.1 Japan G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 9.3 Japan G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 10.1 Southeast Asia G-CSF and G-CSF Biosimilars Sales by Company
    • 10.1.1 Southeast Asia G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 10.2 Southeast Asia G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 10.2.1 Southeast Asia G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India G-CSF and G-CSF Biosimilars Market Facts & Figures

  • 11.1 India G-CSF and G-CSF Biosimilars Sales by Company
    • 11.1.1 India G-CSF and G-CSF Biosimilars Sales by Company (2016-2021)
    • 11.1.2 India G-CSF and G-CSF Biosimilars Revenue by Company (2016-2021)
  • 11.2 India G-CSF and G-CSF Biosimilars Sales Breakdown by Type
    • 11.2.1 India G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2016-2021)
    • 11.2.2 India G-CSF and G-CSF Biosimilars Sales Breakdown by Type (2022-2027)
  • 11.3 India G-CSF and G-CSF Biosimilars Sales Breakdown by Application
    • 11.3.1 India G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2016-2021)
    • 11.3.2 India G-CSF and G-CSF Biosimilars Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in G-CSF and G-CSF Biosimilars Business

  • 12.1 Pfizer
    • 12.1.1 Pfizer Corporation Information
    • 12.1.2 Pfizer Business Overview
    • 12.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
    • 12.1.5 Pfizer Recent Development
  • 12.2 Novartis
    • 12.2.1 Novartis Corporation Information
    • 12.2.2 Novartis Business Overview
    • 12.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Novartis G-CSF and G-CSF Biosimilars Products Offered
    • 12.2.5 Novartis Recent Development
  • 12.3 Roche
    • 12.3.1 Roche Corporation Information
    • 12.3.2 Roche Business Overview
    • 12.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Roche G-CSF and G-CSF Biosimilars Products Offered
    • 12.3.5 Roche Recent Development
  • 12.4 Merck & Co.
    • 12.4.1 Merck & Co. Corporation Information
    • 12.4.2 Merck & Co. Business Overview
    • 12.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Products Offered
    • 12.4.5 Merck & Co. Recent Development
  • 12.5 Sanofi
    • 12.5.1 Sanofi Corporation Information
    • 12.5.2 Sanofi Business Overview
    • 12.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Sanofi G-CSF and G-CSF Biosimilars Products Offered
    • 12.5.5 Sanofi Recent Development
  • 12.6 Johnson & Johnson
    • 12.6.1 Johnson & Johnson Corporation Information
    • 12.6.2 Johnson & Johnson Business Overview
    • 12.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Products Offered
    • 12.6.5 Johnson & Johnson Recent Development
  • 12.7 Gilead Science
    • 12.7.1 Gilead Science Corporation Information
    • 12.7.2 Gilead Science Business Overview
    • 12.7.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Gilead Science G-CSF and G-CSF Biosimilars Products Offered
    • 12.7.5 Gilead Science Recent Development
  • 12.8 GlaxoSmithKline
    • 12.8.1 GlaxoSmithKline Corporation Information
    • 12.8.2 GlaxoSmithKline Business Overview
    • 12.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Products Offered
    • 12.8.5 GlaxoSmithKline Recent Development
  • 12.9 AbbVie
    • 12.9.1 AbbVie Corporation Information
    • 12.9.2 AbbVie Business Overview
    • 12.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 AbbVie G-CSF and G-CSF Biosimilars Products Offered
    • 12.9.5 AbbVie Recent Development
  • 12.10 Amgen
    • 12.10.1 Amgen Corporation Information
    • 12.10.2 Amgen Business Overview
    • 12.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Amgen G-CSF and G-CSF Biosimilars Products Offered
    • 12.10.5 Amgen Recent Development
  • 12.11 AstraZeneca
    • 12.11.1 AstraZeneca Corporation Information
    • 12.11.2 AstraZeneca Business Overview
    • 12.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Products Offered
    • 12.11.5 AstraZeneca Recent Development
  • 12.12 Bayer
    • 12.12.1 Bayer Corporation Information
    • 12.12.2 Bayer Business Overview
    • 12.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Bayer G-CSF and G-CSF Biosimilars Products Offered
    • 12.12.5 Bayer Recent Development

13 G-CSF and G-CSF Biosimilars Manufacturing Cost Analysis

  • 13.1 G-CSF and G-CSF Biosimilars Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of G-CSF and G-CSF Biosimilars
  • 13.4 G-CSF and G-CSF Biosimilars Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 G-CSF and G-CSF Biosimilars Distributors List
  • 14.3 G-CSF and G-CSF Biosimilars Customers

15 Market Dynamics

  • 15.1 G-CSF and G-CSF Biosimilars Market Trends
  • 15.2 G-CSF and G-CSF Biosimilars Drivers
  • 15.3 G-CSF and G-CSF Biosimilars Market Challenges
  • 15.4 G-CSF and G-CSF Biosimilars Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    The global G-CSF and G-CSF Biosimilars market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global G-CSF and G-CSF Biosimilars market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

    Segment by Type
    Blood Disorders
    Oncology Diseases
    Chronic And Autoimmune Diseases
    Growth Hormone Deficiencies

    Segment by Application
    Human Growth Hormone
    Erythropoietin
    Monoclonal Antibodies
    Insulin
    Interferon

    The G-CSF and G-CSF Biosimilars market is analysed and market size information is provided by regions (countries). Segment by Application, the G-CSF and G-CSF Biosimilars market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

    By Company
    Pfizer
    Novartis
    Roche
    Merck & Co.
    Sanofi
    Johnson & Johnson
    Gilead Science
    GlaxoSmithKline
    AbbVie
    Amgen
    AstraZeneca
    Bayer

    Buy now